Related Funds
Fund Name | Location |
Achmea | The Netherlands, Utrecht, Zeist |
APIDC Venture Capital | Hyderabad, India, Telangana |
Azmi Global | - |
Boyi Investment Development | China, Futian, Guangdong |
Cambridge SamsungPartners | Boston, Massachusetts, United States |
Capinfo Company | Beijing, Beijing, China |
ChangePartners | Brazil, Rio Grande do Sul, Viamão |
DaGrosa Capital Partners LLC | Florida, Miami, United States |
Dongguanshi Heshan Guquqn Touzi Zhongxin | China, Dongguang, Guangdong |
Gamerforce Ventures | Central, Central Region, Singapore |
Gen3 Ventures | California, San Francisco, United States |
Golden Sunflower Capital | Beijing, China, Haidian |
Hangzhou Zhiji Touzi | China, Hangzhou, Zhejiang |
Inabata | Japan, Osaka, Osaka Prefecture |
Project 11 Ventures | Boston, Massachusetts, United States |
Science Blockchain | California, Los Angeles, United States |
The IIIT-H Foundation | Andhra Pradesh, Hyderabad, India |
Willoughby Capital | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Dimension Therapeutics | $30M | 23 Jun 2014 | Cambridge, Massachusetts, United States | ||
Blueprint Medicines | $25M | 07 Jan 2014 | Cambridge, Massachusetts, United States | ||
NeuroTherapeutics Pharma | $43M | 20 May 2010 | Chicago, Illinois, United States | ||
Cardiokine | $50M | 01 May 2006 | Philadelphia, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Dimension Therapeutics | $30M | 23 Jun 2014 | Cambridge, Massachusetts, United States | ||
Blueprint Medicines | $25M | 07 Jan 2014 | Cambridge, Massachusetts, United States | ||
NeuroTherapeutics Pharma | $43M | 20 May 2010 | Chicago, Illinois, United States | ||
Cardiokine | $50M | 01 May 2006 | Philadelphia, Pennsylvania, United States |